117 related articles for article (PubMed ID: 30895944)
21. Squamous Cell Carcinoma: An Update on Diagnosis and Treatment.
Combalia A; Carrera C
Dermatol Pract Concept; 2020 Jul; 10(3):e2020066. PubMed ID: 32642314
[TBL] [Abstract][Full Text] [Related]
22. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Larkin J; Chiarion-Sileni V; Gonzalez R; Grob JJ; Rutkowski P; Lao CD; Cowey CL; Schadendorf D; Wagstaff J; Dummer R; Ferrucci PF; Smylie M; Hogg D; Hill A; Márquez-Rodas I; Haanen J; Guidoboni M; Maio M; Schöffski P; Carlino MS; Lebbé C; McArthur G; Ascierto PA; Daniels GA; Long GV; Bastholt L; Rizzo JI; Balogh A; Moshyk A; Hodi FS; Wolchok JD
N Engl J Med; 2019 Oct; 381(16):1535-1546. PubMed ID: 31562797
[TBL] [Abstract][Full Text] [Related]
23. The Role of the Immune System in Cutaneous Squamous Cell Carcinoma.
Bottomley MJ; Thomson J; Harwood C; Leigh I
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022866
[TBL] [Abstract][Full Text] [Related]
24. The vitamin D analogue calcipotriol promotes an anti-tumorigenic phenotype of human pancreatic CAFs but reduces T cell mediated immunity.
Gorchs L; Ahmed S; Mayer C; Knauf A; Fernández Moro C; Svensson M; Heuchel R; Rangelova E; Bergman P; Kaipe H
Sci Rep; 2020 Oct; 10(1):17444. PubMed ID: 33060625
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
26. High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy.
Hirayama AV; Gauthier J; Hay KA; Voutsinas JM; Wu Q; Pender BS; Hawkins RM; Vakil A; Steinmetz RN; Riddell SR; Maloney DG; Turtle CJ
Blood; 2019 Aug; 134(7):636-640. PubMed ID: 31648294
[TBL] [Abstract][Full Text] [Related]
27. Calcipotriol ointment shows comparable efficacy to topical steroids in chronic hand eczema.
Juntongjin P; Pongprasert R
Dermatol Ther; 2019 Jul; 32(4):e12956. PubMed ID: 31070845
[TBL] [Abstract][Full Text] [Related]
28. Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
Gutzmer R; Wiegand S; Kölbl O; Wermker K; Heppt M; Berking C
Dtsch Arztebl Int; 2019 Sep; 116(37):616-626. PubMed ID: 32048593
[TBL] [Abstract][Full Text] [Related]
29. Update in the Management of Basal Cell Carcinoma.
Basset-Seguin N; Herms F
Acta Derm Venereol; 2020 Jun; 100(11):adv00140. PubMed ID: 32346750
[TBL] [Abstract][Full Text] [Related]
30. Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Stratigos AJ; Sekulic A; Peris K; Bechter O; Prey S; Kaatz M; Lewis KD; Basset-Seguin N; Chang ALS; Dalle S; Orland AF; Licitra L; Robert C; Ulrich C; Hauschild A; Migden MR; Dummer R; Li S; Yoo SY; Mohan K; Coates E; Jankovic V; Fiaschi N; Okoye E; Bassukas ID; Loquai C; De Giorgi V; Eroglu Z; Gutzmer R; Ulrich J; Puig S; Seebach F; Thurston G; Weinreich DM; Yancopoulos GD; Lowy I; Bowler T; Fury MG
Lancet Oncol; 2021 Jun; 22(6):848-857. PubMed ID: 34000246
[TBL] [Abstract][Full Text] [Related]
31. Current therapies for actinic keratosis.
Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
[TBL] [Abstract][Full Text] [Related]
32. Top 10 Challenges in Cancer Immunotherapy.
Hegde PS; Chen DS
Immunity; 2020 Jan; 52(1):17-35. PubMed ID: 31940268
[TBL] [Abstract][Full Text] [Related]
33. Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment.
Azin M; Mahon AB; Isaacman S; Seaman JE; Allen IE; Szarek M; Cornelius LA; Demehri S
JID Innov; 2022 May; 2(3):100104. PubMed ID: 35310879
[No Abstract] [Full Text] [Related]
34. Topical Immunotherapy for Actinic Keratosis and Field Cancerization.
Bernal Masferrer L; Gracia Cazaña T; Bernad Alonso I; Álvarez-Salafranca M; Almenara Blasco M; Gallego Rentero M; Juarranz de la Fuente Á; Gilaberte Y
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539468
[TBL] [Abstract][Full Text] [Related]
35. miR-184 represses β-catenin and behaves as a skin tumor suppressor.
Turovsky L; Kheshaiboun G; Yassen G; Nagosa S; Boyango I; Amitai-Lange A; Bhattacharya S; Ilan N; Vlodavsky I; Aberdam D; Shalom-Feuerstein R; Avitan-Hersh E
Cell Death Dis; 2024 Feb; 15(2):174. PubMed ID: 38409173
[TBL] [Abstract][Full Text] [Related]
36. Reactive Keratoacanthoma Following Treatment with 5-Fluorouracil.
Paradkar KA; Plotner AN
J Clin Aesthet Dermatol; 2023 Dec; 16(12):55-56. PubMed ID: 38125667
[TBL] [Abstract][Full Text] [Related]
37. Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches.
Hasan N; Nadaf A; Imran M; Jiba U; Sheikh A; Almalki WH; Almujri SS; Mohammed YH; Kesharwani P; Ahmad FJ
Mol Cancer; 2023 Oct; 22(1):168. PubMed ID: 37803407
[TBL] [Abstract][Full Text] [Related]
38. Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers.
Azin M; Ngo KH; Hojanazarova J; Demehri S
JID Innov; 2023 Nov; 3(6):100221. PubMed ID: 37731472
[TBL] [Abstract][Full Text] [Related]
39. Actinic Keratoses: A Prospective Pilot Study on a Novel Formulation of 4% 5-Fluorouracil Cream and a Review of Other Current Topical Treatment Options.
Toffoli L; Dianzani C; Bonin S; Guarneri C; Guarneri F; Giuffrida R; Zalaudek I; Conforti C
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296918
[TBL] [Abstract][Full Text] [Related]
40. Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers.
Sun W; Liu R; Gao X; Lin Z; Tang H; Cui H; Zhao E
Biomark Res; 2023 May; 11(1):48. PubMed ID: 37147729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
